Literature DB >> 28886944

Attitudes towards Zika screening and vaccination acceptability among pregnant women in Malaysia.

Li Ping Wong1, Haridah Alias2, Jamiyah Hassan3, Sazaly AbuBakar4.   

Abstract

The aim of this study was to examine the willingness of pregnant women to have prenatal screening for the Zika virus (ZIKV). Secondly, the study also assessed the acceptability of a hypothetical Zika vaccination and its association with the health belief model (HBM) constructs. A cross-sectional study was conducted from 4th October to 11th November 2016, among pregnant women who attended antenatal care at the University Malaya Medical Centre (UMMC), Kuala Lumpur, Malaysia. The majority (81.8%) was willing to be tested for ZIKV and 78% felt that their spouse would be willing to be tested for ZIKV. A total of 94% expressed a willingness to receive a Zika vaccination if available. The participants expressed high perceived benefits of a ZIKV vaccination. Although many have a high perception of the severity of ZIKV, the proportion with a strong perception of their susceptibility to ZIKV was low. In the multivariate analysis of all the HBM constructs, cue-to-action, namely physician recommendation (odds ratio [OR]=2.288; 95% confidence interval [CI] 1.093-4.793) and recommendation from friends or relatives (OR=4.030; 95% CI 1.694-9.587), were significantly associated with a willingness to be vaccinated against ZIKV. The favourable response to a Zika vaccination implies that more research attention has to be given to develop a vaccine against ZIKV. Should the vaccine be available in the future, publicity and healthcare providers would play a vital role in ensuring vaccine uptake among pregnant women.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Pregnant women; Screening; Vaccination; Zika

Mesh:

Year:  2017        PMID: 28886944     DOI: 10.1016/j.vaccine.2017.08.074

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Pregnant women's attitudes toward Zika virus vaccine trial participation.

Authors:  Ilona Telefus Goldfarb; Elana Jaffe; Kaitlyn James; Anne Drapkin Lyerly
Journal:  Vaccine       Date:  2018-09-27       Impact factor: 3.641

2.  Clinical Trials and Administration of Zika Virus Vaccine in Pregnant Women: Lessons (that Should Have Been) Learned from Excluding Immunization with the Ebola Vaccine during Pregnancy and Lactation.

Authors:  David A Schwartz
Journal:  Vaccines (Basel)       Date:  2018-12-04

Review 3.  Epidemic preparedness: Prenatal Zika virus screening during the next epidemic.

Authors:  Luxi Qiao; Celina M Turchi Martelli; Amber I Raja; Nuria Sanchez Clemente; Thalia Velho Barreto de Araùjo; Ricardo Arraes de Alencar Ximenes; Demócrito de Barros Miranda-Filho; Anna Ramond; Elizabeth B Brickley
Journal:  BMJ Glob Health       Date:  2021-06

4.  Knowledge and Determinants of Behavioral Responses to the Pandemic of COVID-19.

Authors:  Gang Lv; Jing Yuan; Stephanie Hsieh; Rongjie Shao; Minghui Li
Journal:  Front Med (Lausanne)       Date:  2021-06-09

5.  United States Travelers' Concern about Zika Infection and Willingness to Receive a Hypothetical Zika Vaccine.

Authors:  Nadja A Vielot; Lola Stamm; James Herrington; Linda Squiers; Bridget Kelly; Lauren McCormack; Sylvia Becker-Dreps
Journal:  Am J Trop Med Hyg       Date:  2018-04-19       Impact factor: 2.345

6.  Pregnant women's perceptions of risks and benefits when considering participation in vaccine trials.

Authors:  Elana Jaffe; Anne Drapkin Lyerly; Ilona Telefus Goldfarb
Journal:  Vaccine       Date:  2020-09-04       Impact factor: 3.641

Review 7.  Using immunisation caregiver journey interviews to understand and optimise vaccination uptake: lessons from Sierra Leone.

Authors:  Mohamed F Jalloh; Benjamin Hickler; Lauren E Parmley; Roberta Sutton; Shibani Kulkarni; Anthony Mansaray; Oliver Eleeza; Palak Patel; Elisabeth Wilhelm; Laura Conklin; Adewale Akinjeji; Mame Toure; Brent Wolff; Dimitri Prybylski; Aaron S Wallace; Maria Lahuerta
Journal:  BMJ Glob Health       Date:  2021-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.